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I3Poxviruses are large double-stranded DNA viruses that replicate exclusively in the cytoplasm of infected cells
within discrete compartments termed viral factories. Recent work has shown that the prototypical poxvirus,
Vaccinia Virus (VacV) sequesters components of the eukaryotic translation initiation complex eIF4F within
viral factories while also stimulating formation of eIF4F complexes. However, the forces that govern these
events remain unknown. Here, we show that maximal eIF4F formation requires viral DNA replication and
the formation of viral factories, suggesting that sequestration functions to promote eIF4F assembly, and iden-
tify the ssDNA-binding protein, I3 as a viral factor that interacts and co-localizes with the eIF4F scaffold
protein, eIF4G. Although it did not adversely affect host or viral protein synthesis, I3 speciﬁcally mediated
the binding of eIF4G to ssDNA. Combined, our ﬁndings offer an explanation for the speciﬁc pattern and
temporal process of eIF4G redistribution and eIF4F complex assembly within VacV-infected cells.
© 2012 Elsevier Inc. All rights reserved.Introduction
Among the poxviruses that can infect humans, Variola Virus
(VarV) is the causative agent of smallpox while Vaccinia Virus
(VacV) was used as a vaccine in the eradication of smallpox and has
become the laboratory prototype for the study of poxvirus infection
(Moss, 2007). Both VarV and VacV belong to the orthopoxvirus
genus, with close genetic, morphological and host range similarities.
Orthopoxviruses are large, double-stranded DNA viruses whose ge-
nomes average 200 kbp, with VacV encoding approximately 200
genes. Poxviruses replicate exclusively in the cytoplasm of infected
cells. After cell fusion and entry viral cores traverse the cytoplasm
to speciﬁc sub-cellular sites that are the precursors of viral DNA syn-
thesis. At early stages these cores rapidly produce and exude mRNAs
due to the presence of a complete transcription system for early viral
gene expression. As the infection proceeds the virus forms structures
termed viral factories or replication compartments in the cytoplasm
of the infected cell. Each incoming virus is capable of forming a
unique replication compartment and these structures show a remark-
able degree of self-sufﬁciency in terms of replicating viral DNA and
transcription of the viral genome.
Despite this impressive compartmentalization and self-sufﬁciency
poxviruses, like all viruses, remain dependent upon the host cell pro-
tein synthesis machinery to translate viral mRNAs into proteinsol of Medicine, New York, NY
.
rights reserved.(Walsh and Mohr, 2011). Similar to host messages, VacV mRNAs
have a 7-Methyl GTP cap at their 5′ end (Boone and Moss, 1977;
Martin and Moss, 1975; Venkatesan et al., 1980). Within the host
cell a complex of eukaryotic translation initiation factors (eIFs),
termed eIF4F plays a critical role in regulating the translation of
capped messages ((Sonenberg and Hinnebusch, 2009) and Fig. 1A).
eIF4F consists of eIF4E; a small cap-binding protein, eIF4A; an RNA
helicase that facilitates ribosomal scanning and eIF4G; a large scaf-
folding protein on which the complex is built. In addition, polyA-
binding protein (PABP) binds both the 3′ end polyA-tail of mRNAs
and eIF4G, circularizing and stimulating the translation of mature
messages ((Mangus et al., 2003; Sonenberg and Hinnebusch, 2009)
and Fig. 1A). Finally, eIF4G also associates with the 40S ribosome
through bridging interactions with eIF3 (Hinnebusch, 2006). eIF4F,
therefore, plays a central role in recruiting the protein synthesis ma-
chinery to fully processed capped mRNAs to initiate their translation.
The assembly of eIF4F complexes is regulated, at least in part, by
small eIF4E-binding proteins (4E-BPs). In their hypophosphorylated
state, 4E-BPs act as translational repressors by competing with eIF4G
for the same binding site on eIF4E (Fig. 1A). Signaling through the
mTOR pathway results in 4E-BP phosphorylation, generating electro-
static repulsion that releases eIF4E to allow it to interact with eIF4G
(Hara et al., 1997; Sonenberg and Hinnebusch, 2009; von Manteuffel
et al., 1997). In contrast to many RNA viruses that inactivate eIF4F
function, a growing number of DNA viruses are being found to stimu-
late the assembly of translation initiation complexes tomaximize viral
protein production (Arias et al., 2009; Castelló et al., 2009;
Kudchodkar et al., 2004; McMahon et al., 2011; Moorman and
Fig. 1. A polypeptide synthesized in VacV-infected cells associates with eIF4G. (A) Recruitment of ribosomes to capped mRNAs by the translation initiation complex eIF4F. The 5′ 7-
Methyl-GTP (cap) of mRNAs is bound by eIF4E, which in turn is bound by the scaffold protein, eIF4G. The RNA helicase, eIF4A also binds eIF4G to facilitate ribosome scanning. PolyA-
binding protein (PABP) binds the n-terminus of eIF4G and the polyA-tail, bridging 5′ and 3′ ends of the mRNA. eIF4G indirectly recruits the 40S ribosome through interactions with
eIF3. Formation of the eIF4F complex is repressed by small eIF4E-binding proteins (4E-BPs), which competitively inhibit eIF4E binding to eIF4G. In response to various stimuli mTOR
signaling phosphorylates 4E-BPs, releasing eIF4E to join the eIF4F complex. (B) Serum starved NHDFs were mock-infected or infected with VacV at m.o.i. 10 for the indicated time in
hours post infection (h.p.i.). 1 h prior to sample preparation cultures were metabolically labeled with
35
S-methionine/cysteine. Whole cell extracts were resolved by SDS-PAGE and
ﬁxed dried gels exposed to x-ray ﬁlm. Migration of molecular weight markers (in kDa) is indicated to the left. Asterisks indicate proteins differentially-expressed at intermediate
stage infection. (C) Serum starved NHDFs were mock-infected (M) or infected (V) at m.o.i. 5 for 15 h then metabolically labeled for 1 h. Soluble cell extracts were prepared and
immunoprecipitated with anti-eIF4G antiserum. Immune-complex and input samples were resolved by SDS-PAGE and ﬁxed, dried gels were exposed to x-ray ﬁlm. Migration of
molecular weight standards in kDa is indicated to the left. (D) Serum starved NHDFs were infected as described in C and metabolically labeled soluble cell extracts were prepared
at 16 or 24 h.p.i. then immunoprecipitated with pre-immune serum (PI) or anti-eIF4G (4G) antiserum, as indicated. Immune complexes were resolved by SDS-PAGE and ﬁxed, dried
gels exposed to x-ray ﬁlm. Migration of molecular weight markers in kDa is indicated to the left.
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Walsh et al., 2005, 2008). Distinct from other mammalian DNA virus-
es, the Poxviridae and Asfarviridae, of which African Swine Fever Virus
(ASFV) is the sole member, replicate exclusively in the cytosol of
infected cells. Recent work has shown that in addition to stimulating
eIF4F assembly both VacV and ASFV cause the redistribution of host
translation factors to viral replication compartments (Castelló et al.,
2009; Katsafanas and Moss, 2007; Walsh et al., 2008). How this rear-
rangement of the host translation system is accomplished remains un-
known. Here, we show that eIF4F assembly is driven by events linked
to viral DNA synthesis and factory formation and describe the identi-
ﬁcation of a VacV-encoded factor that associates with the eIF4F scaf-
fold protein, eIF4G and recruits it to ssDNA.Results
Identiﬁcation of a VacV protein that binds eIF4G
Transformed or immortalized cell lines are frequently metaboli-
cally hyperactive, containing high basal levels of eIF4F and highly ac-
tivated regulatory kinases that can mask the ability of some viruses to
manipulate their activity. In contrast, the lowered metabolic state of
serum-starved primary cells offers a means to study the ability of vi-
ruses to stimulate their host's translation system (Kudchodkar et al.,
2004; Walsh and Mohr, 2004, 2006; Walsh et al., 2005), including
both the redistribution and assembly of eIF4F complexes during
VacV infection and the potential connections between these two
Fig. 2. The eIF4G-associated polypeptide in VacV-infected cells is not detected in PABP
immune complexes. (A) Serum-starved NHDFs were mock-infected (M) or infected
(V) and metabolically labeled soluble cell extracts were prepared 16 h.p.i. as described
in Fig. 1. Extracts were immunoprecipitated with anti-eIF4G or anti-PABP antiserum.
Immune-complex and input samples were resolved by SDS-PAGE and ﬁxed, dried
gels exposed to x-ray ﬁlm. Molecular weight markers are to the left. (B) Serum-
starved NHDF cells were infected at m.o.i. 10 for 18 h then soluble cell extracts were
prepared and immunoprecipitated with anti-eIF4G or anti-PABP antiserum. Levels of
PABP and eIF4E in immune complexes and input samples were examined by western
blotting.
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VacV recruits translation factors to viral factories we explored the
possibility that a speciﬁc viral protein, or cellular protein induced
during infection, might function through direct interaction with the
eIF4F complex. To screen for such newly synthesized proteins we
ﬁrst took the approach of immunoprecipitating the scaffold protein,
eIF4G from metabolically labeled uninfected and infected serum-
starved primary Normal Human Diploid Fibroblasts (NHDFs). In
NHDFs that were serum-starved for 5 days the viral lifecycle was pro-
tracted and reached an intermediate phase by 16 h.p.i., characterized
by the incomplete inhibition of host protein synthesis and continued
synthesis of mid-phase viral proteins that were not evident at late
stages of infection (Moss, 2007) (Fig. 1B). Initially the intermediate
phase of infection was screened by metabolically labeling uninfected
and infected cultures from 15 to 16 h.p.i. then soluble cell extracts
were nuclease treated using a cocktail of RNAse A, micrococcal nucle-
ase and RNAse T1 previously shown to eliminate RNA-mediated in-
teraction of proteins with eIF4G (Walsh and Mohr, 2006) and
cleared with pre-immune serum. Anti-eIF4G immune complexes
were recovered from cleared extracts then resolved by SDS-PAGE
and ﬁxed, dried gels were exposed to x-ray ﬁlm, detecting proteins
actively translated during the labeling period. In immune complexes
from mock-infected samples eIF4G and a number of associated pro-
teins were evident, while in VacV-infected samples these compo-
nents were present but their intensity was decreased due to the
partial suppression of host translation at this point (Fig. 1C). Notably,
however, a single protein migrating at approximately 34 kDa was as-
sociated with eIF4G isolated from infected cell extracts that was not
present in mock-infected samples. The signal intensity from this co-
immunoprecipitating polypeptide declined by 24 h.p.i. (Fig. 1D), sug-
gesting that it was either no longer associated with eIF4G at late
stages of infection or no longer actively synthesized at this point.
To further explore the speciﬁcity of its interaction with eIF4G we
then examined whether this protein was also evident in anti-PABP
immune complexes. PABP is an abundant RNA-binding protein in-
volved in a variety of cellular processes including the regulation of
translation but exhibits a distinct distribution pattern from that of
eIF4G in infected cells (Mangus et al., 2003; Smith and Gray, 2010;
Walsh et al., 2008). Again, soluble cell extracts were prepared from
metabolically labeled mock or VacV-infected NHDFs and nuclease-
treated then immunoprecipitated with either anti-eIF4G or anti-
PABP antiserum. When immune complexes were analyzed the
~34kDa protein was only readily detected in anti-eIF4G immune
complexes (Fig. 2A). While the cap-binding protein, eIF4E was also
readily recovered in association with eIF4G considerably less eIF4E
was evident in anti-PABP immune complexes, despite efﬁcient target
antigen recovery (Fig. 2B). This suggested that only a relatively small
amount of the total pool of PABP, an abundant multifunctional cellu-
lar protein, was associated with eIF4F complexes in these cells. Com-
bined with the fact that in infected cells PABP remains largely
excluded from factories (Walsh et al., 2008), this may also explain
why PABP did not efﬁciently associate with the ~34kDa protein
found associated with eIF4G. As such, the ~34kDa protein appeared
to be speciﬁc in its interaction and did not randomly associate with
general host factors that bind RNA.
To determine the identity of this protein soluble nuclease-treated
cell extracts were prepared from mock and VacV-infected cells as de-
scribed above then anti-eIF4G immune complexes were resolved by
SDS-PAGE. When gels were silver-stained a single protein was evi-
dent in VacV-infected samples that were not present in mock-
infected samples, migrating at approximately 34 kDa (Fig. 3A). This
band was excised and analyzed by mass spectrometry. In various in-
dependent experiments an average of 4–6 peptides was identiﬁed,
all of which corresponded to the VacV ssDNA-binding phosphopro-
tein I3 (GI no. 66275869) with sequence coverage ranging from
18.2 to 23%. I3 has previously been shown to be an early-to-intermediate stage protein whose synthesis declines at late stages of
infection (Rochester and Traktman, 1998), in agreement with the
ready detection of actively synthesized I3 bound to eIF4G at interme-
diate but not late stages of infection in Fig. 1D. It is also notable that
VacV encodes a number of ssDNA- and RNA-binding proteins that
are produced in infected cells (Moss, 2007) but which were not evi-
dent in eIF4G immune complexes (Fig. 1C), adding further support
for the speciﬁcity of the I3 interaction suggested by eIF4G and PABP
co-immunoprecipitation experiments.
To conﬁrm the interaction of I3 with eIF4F by an alternative, non-
immune-based assay we determined whether I3 was recovered with
Fig. 3. Identiﬁcation of the eIF4G-associated protein as VacV I3. (A) NHDFs were mock-infected (M) or infected (V) for 16 h. Soluble cell extracts were prepared and immunopre-
cipitated with anti-eIF4G antiserum. Immune-complexes were resolved by SDS-PAGE, gels were silver-stained and a speciﬁc band migrating at 34 kDa only present in infected sam-
ples was excised and identiﬁed by mass spectrometry. A representative image from silver-stained gels, with an asterisk indicating the 34 kDa protein in question, along with a
sample MS/MS spectra of a peptide from I3 is shown. (B) 293 cells were mock-infected (M) or infected (V) at m.o.i. 5 for 16 h. Soluble cell extracts were prepared then eIF4E
and associated proteins were recovered on 7-Methyl GTP resin in the presence (+) or absence (−) of competing free 7-Methyl GTP (3 mM). Resin-associated and input samples
were analyzed by western blotting with the indicated antisera. All images were from the same blots and exposures, cropped to remove replicate experiments. A slower-migrating
non-speciﬁc band, indicated with an asterisk, is evident in all cap-bound samples. (C) Schematic representation of the GST-tagged N-, M- and C-terminal regions of eIF4G used in
binding assays. The location of binding sites for PABP, eIF4E and RNA binding domains within these fragments are indicated by the shaded boxes. The corresponding amino acid
numbers of each fragment is given in brackets. Lower Panels: Binding reactions were performed between his-I3 and each of the GST-fused eIF4G fragments, together with dialysis
buffer alone as a control (−). Glutathione-sepharose complexes were washed and boiled in Laemmli buffer then analyzed by western blotting using ant-GST and anti-histidine
antibodies to detect eIF4G fragments and I3, respectively. Input samples demonstrate the presence of I3 in all reactions.
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(cap) sepharose. 293 cells, which contain higher levels of eIF4F con-
venient for binding assays, were mock-infected or infected for 16 h
then cap-binding eIF4F complexes were recovered from RNAse A-
treated soluble cell extracts on cap-sepharose. When complexes
were analyzed by western blotting I3 was readily detectable in
infected cell samples and, together with the eIF4F components
eIF4E and eIF4G, binding was competitively inhibited by the additionof free 7-Methyl GTP to extracts (Fig. 3B). This demonstrated that I3
associated with cap-binding eIF4F, even at the late stages of infection
reached in 293 cells by 16 h. Finally, we examined whether I3 bound
to eIF4G directly. To do this, his-tagged I3 and GST-tagged N-(aa157-
626), M-(aa627-1045) or C-(aa1045-1560) terminal fragments of
eIF4G (diagram Fig. 3C and (Cuesta et al., 2000)) were isolated from
benzonase-treated BL21 cells. 200 ng his-I3 was incubated for 2 h
with glutathione-sepharose with either dialysis buffer alone or
15I. Zaborowska et al. / Virology 425 (2012) 11–22together with 1 μg of each GST-tagged eIF4G fragment then resin-
bound complexes were washed and analyzed by western blotting.
While each eIF4G fragment was equally recovered, with the slower
mobility of N-4G through SDS-PAGE gels due to structural complexity
in the N-terminal domain of eIF4G, I3 was found speciﬁcally bound to
the C-terminal fragment of eIF4G (Fig. 3C).
Co-localization of I3 and eIF4G in infected NHDFs
Having established its interaction with eIF4G, we next examined
whether I3 and eIF4G co-localized in infected cells. NHDFs were
mock-infected or infected for 22 h, then ﬁxed and analyzed by immuno-
ﬂuorescence using mouse anti-I3 and rabbit anti-eIF4G antibodies. InFig. 4. Co-localization of I3 and eIF4G in infected NHDFs. NHDFs were either mock-infecte
panels) or presence (lower three panels) of PAA. Cells were ﬁxed and analyzed by imm
DNA was stained using Hoechst. Arrows indicate the location of viral factories (middle thr
panels).uninfected cells, no I3 staining was evident and eIF4G was detected in
both the nucleus and the cytoplasm (Fig. 4, upper panel set), with nota-
ble concentrations in perinuclear regions similar to staining patterns
reported by others (Willett et al., 2006). In infected cells, large viral fac-
tories were evident as Hoechst-stained structures in the cytoplasm that
contained discrete concentrations of eIF4G, as reported previously
(Katsafanas andMoss, 2007;Walsh et al., 2008). eIF4G present in facto-
ries co-localized with I3 (Fig. 4, middle panel sets). Similar patterns of
co-localization were observed in >90% of infected cells. Notably, co-
localization was not absolute in all cases (as evident in panel series 4),
which may represent dynamic interactions between I3 and eIF4G or
I3's multiple functions. However, in all cases there was a high degree
of co-localization between I3 and eIF4G similar to the images presented.d (top panels) or infected with VacV at m.o.i. 5 for 22 h in the absence (middle three
unoﬂuorescence using rabbit anti-eIF4G (red) and mouse anti-I3 (green) antibodies.
ee panels) or sites of viral DNA that are precursors for factory formation (lower three
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viral factory formation by inhibiting viral DNA synthesis using Phos-
phonoacetic Acid (PAA). It has been shown previously that in the
presence of similar inhibitors, I3 is largely distributed throughout
the cytoplasm but forms punctate structures that co-localize with
DNA from incoming viral cores (Domi and Beaud, 2000; Rochester
and Traktman, 1998; Welsch et al., 2003). These are precursors of
viral factories and viral DNA can be faintly visualized by Hoechst
staining. NHDFs were pre-treated with PAA then infected and ana-
lyzed by immunoﬂuorescence as described above. In PAA-treated cul-
tures small DNA-positive structures were evident near host nuclei
(Fig. 4, lower panel sets). Both I3 and eIF4Gwere distributed through-
out the cytoplasm, but both proteins formed punctate spots of co-
localization with viral DNA. Notably, in many cells eIF4G-staining
structures were evident near factories and nuclei, which may repre-
sent ER structures reported by others (Willett et al., 2006) or the
presence of eIF4G in aggresomes, similar to those reported for other
host proteins in VacV-infected cells (Paran et al., 2009). This sug-
gested that I3 interacted with eIF4G prior to viral factory formation,
in line with a potential role in eIF4G retention at sites of factory for-
mation. To conﬁrm this interaction, we examined the effects of PAA
on I3 association with eIF4F complexes. 293 cells were used to recov-
er eIF4F on cap-sepharose to avoid the complication of changes in
eIF4F levels that occur in infected NHDFs. 293 cells were infected in
the presence or absence of PAA then cap-bound proteins were recov-
ered from soluble cell extracts on 7-Methyl GTP-sepharose. As illus-
trated in Fig. 5A, PAA treatment did not affect the accumulation of
I3, characteristic of early-to-intermediate-phase VacV proteins
(Rochester and Traktman, 1998) and did not adversely affect the
binding of I3 to eIF4F. This demonstrated that I3 bound to eIF4F
early in infection and prior to the onset of viral factory formation.
eIF4F assembly in VacV-infected NHDFs is sensitive to PAA
VacV causes increased eIF4F complex formation in normal human
cells (Walsh et al., 2008) but the exact mechanism remains unclear.
The translational repressor 4E-BP1 binds eIF4E at the same site as
eIF4G, competitively inhibiting eIF4E:eIF4G interaction and suppres-
sing eIF4F complex formation. Phosphorylation of 4E-BP1 by mTOR
causes electrostatic repulsion and release of eIF4E. VacV activates
mTOR signaling to promote phosphorylation and inactivation of the
translational repressor, 4E-BP1 (Walsh et al., 2008; Zaborowska and
Walsh, 2009). However, although inhibition of mTOR prevents VacV
from inactivating 4E-BP1, its ability to enhance eIF4F complex forma-
tion is only partially reduced (Zaborowska and Walsh, 2009), sug-
gesting that additional events contribute to eIF4F formation during
infection. PAA, an inhibitor of viral DNA synthesis and factory forma-
tion, has been shown to dampen 4E-BP1 phosphorylation during
VacV infection, leading to the suggestion that late gene products or
viral factory formation are involved (Walsh et al., 2008). However,
the full effects of this inhibitor on eIF4F complex formation have not
been explored while its effects on 4E-BP1 phosphorylation appear
to contradict a recent report that the PI3K–Akt–mTOR pathway is ac-
tivated very early in infection (Soares et al., 2009). To address these
issues we examined the effects of PAA on 4E-BP1:eIF4E binding and
eIF4F assembly in resting primary cells in more detail. Serum-
starved NHDFs were mock-infected or infected with VacV in the pres-
ence or absence of PAA and the levels of eIF4E-bound eIF4G and 4E-
BP1 were examined by recovering eIF4E on 7-Methyl-GTP sepharose.
As reported previously VacV infection stimulated 4E-BP1 phosphory-
lation (Walsh et al., 2008; Zaborowska andWalsh, 2009), evident as a
decrease in antigen mobility through high percentage SDS-PAGE gels
in input samples from infected cells (Fig. 5B). This was reﬂected in re-
duced binding of 4E-BP1 to eIF4E on 7-Methyl GTP resin, which was
accompanied by an increase in the association of eIF4G with eIF4E, in-
dicative of enhanced eIF4F formation. However, although PAAincreased the mobility of 4E-BP1 through high-percentage gels in
input samples (indicated with an arrow in Fig. 5B), suggesting 4E-
BP1 dephosphorylation and similar to previous reports (Walsh et al.,
2008), it did not prevent the release of 4E-BP1 from eIF4E on 7-
Methyl GTP-sepharose (Fig. 5B). In addition, PAA had minimal effects
on the phosphorylation of Akt on either Thr308 or Ser473 residues,
the kinase that acts upstream to stimulate mTOR and 4E-BP1 phos-
phorylation during infection (Soares et al., 2009; Zaborowska and
Walsh, 2009). Overall, this demonstrated that 4E-BP1 was released
from eIF4E prior to viral DNA synthesis and suggested that the effects
of PAA on 4E-BP1 phosphorylation, as measured by altered mobility
through high-percentage gels, may simply reﬂect an altered rate of
phosphate turnover without affecting actual release of the repressor
from eIF4E. As such, 4E-BP1 is inactivated and released from eIF4E
early in infection.
However, despite the release of 4E-BP1 from eIF4E PAA treatment
did suppress the increase in eIF4G binding that occurred in VacV-
infected cultures in the absence of this inhibitor (Fig. 5B). Although
some increase in eIF4E:eIF4G binding was apparent, reﬂective of the
release of 4E-BP1, the effects of PAA suggested that additional forces
beyond the release of 4E-BP1 contributed to the increase in eIF4F
levels observed in VacV-infected cells, possibly linked to the effects
of PAA on the redistribution and concentration of factors within
viral factories (Fig. 4).
I3 promotes the association of eIF4G with ssDNA
Given the association of I3 with eIF4F, we further explored how
I3 might inﬂuence mRNA translation. To determine potential effects
on host translation, the I3L gene was PCR-ampliﬁed from genomic
viral DNA using primers that generated a C-terminally FLAG-
tagged form of I3, which was ligated into a mammalian expression
plasmid. Stable 293 empty vector or I3-expressing lines were gener-
ated by drug selection. Immunoﬂuorescence using monoclonal anti-
I3 antibody demonstrated that FLAG-I3 was predominantly cytoplas-
mic and expressed at detectable levels in approximately 60–70% of
cells, while the ability of FLAG-I3 to associate with eIF4F was con-
ﬁrmed by recovering 7-Methyl GTP complexes from RNAse A-
treated soluble cell extracts followed by western blot analysis
(Fig. 6A). However, metabolic labeling showed no notable differ-
ences in the pattern or rates of cellular protein synthesis between
control or FLAG-I3-expressing cultures (Fig. 6B). We also tested
whether I3 affected translation of RNA isolated from VacV-infected
cells in vitro. Rabbit reticulocyte lysates containing
35
S-Methionine
were programmed with 10 μg total RNA from infected 293 cells in
the presence of dialysis buffer or 200 ng puriﬁed his-I3 and incubat-
ed at 30 °C for 1 h. Samples were then boiled with an equal volume
of 2× Laemmli Buffer and resolved by SDS-PAGE then gels were
ﬁxed, dried and exposed to x-ray ﬁlm (Fig. 6C; upper panel) or an-
alyzed by western blotting with anti-his antibody to conﬁrm the
presence of I3 in reactions (Fig. 6C; lower panel). The presence of
I3 in reactions had no discernable effect on rates or patterns of
viral protein synthesis. As such, I3 did not appear to adversely affect
translation of either host or viral messages. However, it must be
noted that I3 staining in FLAG-I3 lines was heterogenous and far
lower than levels expressed during infection (not shown). As such,
we cannot presently rule out the possibility that I3 inﬂuences trans-
lation when expressed at higher levels. It is also possible that I3 in-
ﬂuences translation in the context of infection by retaining
translation factors within viral factories. The very high afﬁnity of
I3 for ssDNA is thought to explain its retention in viral factories
(Domi and Beaud, 2000; Rochester and Traktman, 1998; Tseng et
al., 1999). We therefore examined the ability of I3 to recruit trans-
lation factors to ssDNA to determine whether its ssDNA-binding and
eIF4G-binding functions were mutually exclusive or potentially con-
tribute to a mechanism of sequestration. Soluble cell extracts were
17I. Zaborowska et al. / Virology 425 (2012) 11–22prepared from FLAG- or FLAG-I3-expressing 293 cells then treated
with RNAse A to prevent potential RNA:ssDNA bridging interactions.
RNAse was then inactivated by the addition of RNAse inhibitor and
precleared extracts were incubated with 5′ biotinylated ssDNA.
Input DNA was recovered on anti-biotin antibody-conjugated
sepharose and associated proteins were analyzed by western blot-
ting. In control extracts a low level of eIF4G binding to either
ssDNA or the sepharose resin was evident (Fig. 6D). However, in
the presence of I3 signiﬁcantly more (16-fold) eIF4G was recovered.
In addition to eIF4G, higher levels of PABP were also bound in the
presence of I3 (Fig. 6D), although background binding of PABP to
ssDNA or the matrix complicated the interpretation of the preciseFig. 5. I3 binding and eIF4F complex formation in PAA-treated cells. (A) 293 cells were mock-
extracts were prepared. Input samples were probed with anti-vaccinia virus antiserum to c
dicated to the left. 7-Methyl GTP-bound and input samples were prepared and analyzed by
to quantify the fold change (F.C.) in I3 binding to cap complexes in PAA-treated samples
mock-infected (M) or infected (V) at m.o.i. 10 in the presence or absence of PAA. 24 h.p
binding eIF4E and associated proteins were recovered on 7-Methyl GTP resin. Beads were bo
with the indicated antibodies. An arrow indicates the migration of hypo-phosphorylated 4E
association of eIF4G or 4E-BP1 with 7-Methyl GTP resin relative to mock-infected samples,degree to which PABP is recruited by eIF4G. However, as I3 does
not appear to interact with PABP (Fig. 2), this demonstrated that
I3 was capable of recruiting eIF4G and eIF4G-associated PABP to
ssDNA. To conﬁrm the speciﬁcity of factor recruitment by I3 the as-
sociation of RBM3 was examined in the same samples. RMB3 is a
cellular protein with both RNA and ssDNA-binding properties that
has been shown to potentially interact with VacV A2 protein, but
not I3 (Dellis et al., 2004; Derry et al., 1995). While RBM3 was
found associated with ssDNA in both extracts its association was
modestly reduced in I3 versus control extracts (Fig. 6D), possibly
due to competition for binding from I3 itself. In addition to
conﬁrming the speciﬁcity of I3 function in eIF4G recruitment, thisinfected (M) or infected (V) in the presence or absence of PAA for 16 h then soluble cell
onﬁrm the effectiveness of PAA treatment. Molecular weight markers (in kDa) are in-
western blotting with the indicated antibodies (right panel). Densitometry was used
compared to untreated samples, arbitrarily set at 1. (B) Serum-starved NHDFs were
.i. soluble cell extracts were prepared and precleared with sepharose 4B before cap-
iled in Laemmli buffer and analyzed, together with input samples, by western blotting
-BP1 in input samples. Densitometry was used to quantify the fold change (F.C.) in the
arbitrarily set to 1.
Fig. 6. I3 does not adversely affect host or viral mRNA translation but recruits eIF4G to ssDNA. (A) Left panel; Control empty-vector and FLAG-I3 cultures were ﬁxed and analyzed by
immunoﬂuorescence using mouse anti-I3 antibody. DNA was stained using Hoechst. Right panel; soluble cell extracts were prepared from control (C) empty-vector or FLAG-I3 (I3)
expressing 293 cells then precleared with Sepharose 4B. Extracts were incubated with 7-Methyl GTP-Sepharose 4B then resin-bound and input samples were analyzed by western
blotting with the indicated antisera. Migration of I3 detected with anti-FLAG antiserum is indicated with the arrow (>). A non-speciﬁc band detected by this antiserum in input
samples just below I3 is indicated by the asterisk. (B) Control (C) or I3-expressing (I3) cells were labeled with
35
S-Methionine for 60 min then lysed in laemmli buffer. Samples
were resolved by SDS-PAGE and gels were ﬁxed, dried and exposed to x-ray ﬁlm. Migration of molecular weight standards (in kDa) is indicated to the left. (C) 10 μg total RNA iso-
lated from VacV-infected cells was translated in rabbit reticulocyte lysates for 60 min the presence of dialysis buffer (−) or his-I3 (+). I3 was detected by using anti-histidine an-
tibody. An intense background band from the reticulocyte lysate prevented longer exposures but his-I3 is clearly evident in samples. (D) Soluble cell extracts were prepared from
FLAG- or FLAG-I3-expressing 293 cells. After RNAse A treatment and inactivation, extracts were precleared with anti-biotin antibody-conjugated sepharose. Precleared extracts
were programmed with 7.5 μg biotin-conjugated ssDNA together with anti-biotin antibody-conjugated sepharose for 2 h. Immune-complexes and input samples were analyzed
by western blotting with the indicated antisera.
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ssDNA in extracts and, thereby, non-speciﬁcally mediating the in-
creased recovery of nucleotide-binding proteins in general.
Discussion
All viruses are dependent upon a host cell to provide the transla-
tional machinery needed for the synthesis of viral proteins. For both
RNA and DNA viruses a key element in the battle to usurp host ribo-
somes is control of the translation initiation complex eIF4F (Walsh
and Mohr, 2011). In addition to modulating cellular signalingpathways that regulate host translation factor activity, a growing
number of viruses are being found to encode proteins that directly in-
teract with the eIF4F complex. Among RNA viruses, rotavirus NSP3
protein (Groft and Burley, 2002; Montero et al., 2006; Piron et al.,
1998; Vende et al., 2000) and the inﬂuenza virus proteins NS1
(Aragón et al., 2000; Burgui et al., 2003) and Polymerase (Burgui et
al., 2007) bind the translation initiation factor eIF4G to mediate selec-
tive translation of viral messages or modulate host protein synthesis,
although hantavirus N protein has recently been shown to take this
approach even further and functionally replaces the eIF4F complex al-
together (Mir and Panganiban, 2008). In the case of DNA viruses,
19I. Zaborowska et al. / Virology 425 (2012) 11–22adenovirus-encoded 100 k protein binds eIF4G, evicting the eIF4E ki-
nase Mnk from assembled complexes and facilitating translation of
viral mRNAs via ribosome shunting (Cuesta et al., 2000; Xi et al.,
2004). HSV-1 encodes another eIF4G-interacting protein, ICP6,
which has homology to cellular chaperones and promotes the assem-
bly of eIF4F complexes (Walsh and Mohr, 2006). In addition, HSV-1
encoded ICP27 interacts with the eIF4G binding protein, PABP to reg-
ulate translation of speciﬁc sub-sets of viral mRNAs (Ellison et al.,
2005; Fontaine-Rodriguez and Knipe, 2008; Fontaine-Rodriguez et
al., 2004; Larralde et al., 2006), while another HSV-1 function, VHS as-
sociates with eIF4A to regulate mRNA turnover (Feng et al., 2005).
HCMV also encodes an ICP27-like protein, UL69 that associates with
PABP and eIF4A (Aoyagi et al., 2010). As such, encoding factors that
interact with the scaffold protein eIF4G or its binding proteins ap-
pears to be a common strategy employed by numerous viruses to en-
able direct manipulation of eIF4F function. Here we demonstrate that
the I3 protein encoded by VacV also associates with eIF4G and can re-
cruit it, along with PABP, to ssDNA.
Unlike many other mammalian DNA viruses, poxviruses and asfar-
viruses replicate exclusively in the cytoplasm of infected cells within
specialized replication compartments. A number of cellular proteins
have been shown to redistribute to viral factories during poxvirus infec-
tionwhile the localization ofmany others, including nucleotide-binding
proteins, remains unaffected (Broyles, 1991; Castro et al., 2003; Hung et
al., 2002; Katsafanas and Moss, 2007; Lin et al., 2008; Paran et al., 2009;
Walsh et al., 2008). As such, the redistribution of factors during infec-
tion appears to be selective and, therefore, likely to bemediated by spe-
ciﬁc functions, as is the case for the recruitment of cellular
topoisomerase II by VacV DNA ligase (Lin et al., 2008). A number of
viral proteins produced early in VacV infection are synthesized in the
cytoplasm but accumulate within viral factories as infection progresses.
Among these, the association of VacV E3 protein with double-stranded
RNA formed as a consequence of viral transcriptional read-through has
been suggested to promote its accumulation within replication com-
partments (Katsafanas and Moss, 2007). Similarly, the formation of
ssDNA in factories likely mediates the accumulation of I3 (Domi and
Beaud, 2000; Rochester and Traktman, 1998; Welsch et al., 2003). The
potential for these proteins to bind to speciﬁc host factors would pro-
vide a means for the virus to selectively organize the protein composi-
tion of viral factories, as opposed to a random diffusion of factors into
these sites. As a virus-encoded ssDNA-binding protein it has been sug-
gested that I3 may play a role in viral DNA replication, recombination
or repair (Rochester and Traktman, 1998; Tseng et al., 1999). Indeed, a
recent report has conﬁrmed I3 functions in both replication and recom-
bination (Gammon and Evans, 2009). Although I3 has been shown to
interact with the viral ribonucleotide reductase (Davis and Mathews,
1993), other I3-interacting proteins have not been reported. However,
BLAST and ELM (eukaryotic linear motif) analysis predicts that I3 con-
tains various protein binding domains and target sites for phosphoryla-
tion by host kinases (unpublished observation). In line with this,
previous studies have suggested that I3 is phosphorylated by a host,
rather than viral, kinase(s) (Rochester and Traktman, 1998). Our ﬁnd-
ings provide the ﬁrst evidence of I3 interaction with a host cell protein
that exhibits the same pattern of redistribution upon VacV infection. As
such, in addition to its role as a viral ssb and like many multifunctional
viral proteins, I3 may also play an important role in sequestering host
factors in poxvirus-infected cells, including those involved in transla-
tional control.
As the number of DNA viruses that are found to be capable of en-
hancing the levels of eIF4F in infected cells increases the mechanisms
by which they accomplish this are just beginning to be elucidated. In
the case of HSV-1, HCMV and VacV enhancement of eIF4G binding to
eIF4E can occur in the absence of signiﬁcant release of the repressor
4E-BP1, suggesting that these viruses can drive complex formation
through additional mechanisms (Kudchodkar et al., 2004; Walsh
and Mohr, 2004; Walsh et al., 2005; Zaborowska and Walsh, 2009).Conversely, in HSV-1-infected cells the release of 4E-BP1 alone does
not appear to be sufﬁcient to drive eIF4F complex formation in the ab-
sence of the viral eIF4F chaperone ICP6 (Walsh and Mohr, 2006). Sim-
ilarly, we show that in VacV-infected cells stimulation of eIF4F
complex formation is reduced in the presence of PAA despite the re-
lease of 4E-BP1 from eIF4E. This suggests that eIF4F assembly in
VacV-infected cells also involves forces in addition to the release of
4E-BP1. VacV enhances eIF4F levels in cell types where initiation fac-
tor and eIF4F complex levels are low, likely by concentrating host
translation factors within viral factories (Katsafanas and Moss,
2007; Walsh et al., 2008). A concentration-dependent process of
eIF4F assembly in serum-starved NHDFs has also been proposed for
human cytomegalovirus (HCMV) (Walsh et al., 2005). HCMV has
not been shown to encode proteins that promote eIF4F formation
and does not redistribute host translation factors. Instead, HCMV
causes a robust increase in the steady-state levels of a number of
host initiation factors, which appears to play a central role in fostering
increased eIF4F formation during infection. In the absence of an in-
crease in factor abundance during VacV infection (Walsh et al.,
2008), creating local concentrations within viral factories likely
achieves the same effect and alters the relative on-off rate of the
eIF4E:eIF4G interaction, tilting the balance towards increased interac-
tion. This is supported by the effects of PAA, which does not adversely
affect I3 association with eIF4F or release of 4E-BP1 but suppresses
initiation factor redistribution and eIF4F assembly (Fig. 5B) (Walsh
et al., 2008). Its ability to recruit eIF4G to ssDNA suggests that I3 is
likely to be involved in these events. However, due to the essential
nature of I3, and similar to previous attempts (Rochester and
Traktman, 1998), we have been unable to recover virus lacking the
I3L gene to directly test this.
In addition to enhancing eIF4F levels in infected cells VacV also
stimulates the recruitment of PABP, despite the fact that only relative-
ly small amounts of the total pool of this protein are actually recruited
into viral factories (Walsh et al., 2008). Here, immunoprecipitation-
based approaches conﬁrmed the increased formation of initiation
complexes and recruitment of PABP, with more eIF4E detected in
both eIF4G and PABP immune complexes recovered from infected
compared to uninfected cell extracts, albeit modest at the intermedi-
ate point examined in this particular experiment. The inefﬁcient re-
covery of eIF4E in association with PABP immune complexes
suggests that only a limited fraction of the total cellular pool of this
multifunctional protein is actually associated with translation initia-
tion complexes, at least in NHDFs. Recruitment of this fraction of
PABP into viral factories by virtue of its association with I3-bound
eIF4F would explain why some PABP does redistribute to these struc-
tures (Walsh et al., 2008). It is likely that, similar to eIF4E, I3 is pre-
sent in PABP immune complexes as part of the eIF4F-associated
fraction of PABP but below detectable levels of this assay. Indeed, al-
though I3 did not freely associate with PABP it did mediate recruit-
ment of PABP to ssDNA in vitro, suggesting that I3 was not
precluded from associating with, and could effectively recruit, PABP-
bound eIF4G. This is in line with our ﬁnding that I3 binds the C-
terminal region of eIF4G, while PABP associates with the N-
terminus of eIF4G (Imataka et al., 1998). Overall, these ﬁndings pro-
vide insight into the mechanisms by which eIF4F is regulated during
VacV infection and identiﬁes a potential viral candidate for eIF4G se-
questration in viral replication compartments.
Materials and methods
Cell culture and viruses
NHDF and 293 cells were cultured in DMEM containing 5% FBS as
described previously (Walsh and Mohr, 2004; Zaborowska and
Walsh, 2009). For serum starvation, conﬂuent cultures of NHDFs
were washed three times in PBS then cultured in DMEM containing
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cultures was performed as described previously (Walsh and Mohr,
2004; Walsh et al., 2008). VacV Western Reserve was a kind gift of
Dr. Stewart Shuman, Memorial Sloan-Kettering, New York, and was
propagated and titered on permissive BSC40 cells.
Cloning, plasmids and proteins
The I3L gene was ampliﬁed from VacV genomic DNA isolated as
described previously (Roper, 2004). To generate FLAG-tagged I3L
the following primers were used, containing EcoR1 and Sal1 restric-
tion sites for cloning. The FLAG sequence is italicized.
Forward:
GCAACT GAATTC CGCCGCC ATG AGTAAGGTAATCAAGAAG
Reverse: GCAACT GTCGAC TCTAGT TCA ctt gtc gtc atc gtc ttt gta gtc
TAC ATT GAA TAT TGG CTT TTC
The ampliﬁed PCR product was gel puriﬁed and digested with
EcoR1-Sal1 then ligated into the EcoR1-Sal1 cloning site of the mam-
malian expression plasmid, pCI-Neo. Ligations were transformed into
DH5α cells and individual colonies were isolated. Recovered plasmids
were analyzed by restriction digestion then sequenced to ensure
cloning ﬁdelity. Stably-expressing 293 cells were established by
transfecting cultures using lipofectamine (Invitrogen) followed by se-
lection with geneticin.
To generate puriﬁed his-tagged I3 the I3L gene was PCR ampliﬁed




The PCR product was then digested with Not1 and Nde1 and ligat-
ed into Not1/Nde1 cloning sites in the bacterial expression plasmid,
pET-15b. To purify protein, the pET-his-I3 plasmid was transformed
into BL-21 cells (Invitrogen). Overnight starter cultures were used
to inoculate 250 ml cultures grown at room temperature until O.D.
600 then induced with IPTG for 30–60 min. His-tagged I3 was puri-
ﬁed by cell lysis followed by benzonase treatment and isolation on
His-Talon columns (Clontech) according to the manufacturer's in-
structions. BL21 cells containing GST-tagged eIF4G fragments and
their puriﬁcation were as described previously (Cuesta et al., 2000;
Walsh and Mohr, 2006). All proteins were dialyzed overnight, with
buffer changes 2 h before and after the overnight dialysis, as de-
scribed previously (Walsh and Mohr, 2006).
In vitro binding reactions and in vitro translation
For eIF4G:I3 binding reactions 20 μl p.b.v. glutathione-sepharose
was washed 3 times in binding buffer [50 mM Hepes, pH 7.4,
100 mM NaCl. 0.5 mMMgCl2, 2 mM EDTA, 2 mM Na3VO4, 25 mM gly-
cerophosphate and complete mini EDTA-free protease inhibitor cock-
tail (Roche)] and blocked at room temperature for 1 h in binding
buffer containing 5% BSA. Binding reactions were performed by rock-
ing the blocked glutathione-sepharose with 1 μg GST-tagged eIF4G
and 200 ng his-I3 in a 200 μl volume of binding buffer containing 1%
BSA and 0.25% NP-40. Controls lacking proteins contained dialysis
buffer.
In vitro translation was performed using rabbit reticulocyte ly-
sates (Promega) in a total volume of 50 μl supplemented with 2 μl
IVT grade
35
S-Methionine (Perkin Elmer), 200 ng I3 protein or equiv-
alent volume of dialysis buffer as control together with 10 μg total
RNA. Total RNA was isolated using Qiagen RNA spin kits from
10 cm2 dishes of 293 cells that had been infected overnight with
VacV at an m.o.i. 10.Western blotting and immunoﬂuorescence
Western blotting was performed as described previously (Walsh
and Mohr, 2004). For immunoﬂuorescence, cells were seeded on cov-
erslips (Fisher) and treated as indicated. Cells were then ﬁxed in 3.7%
formaldehyde/PBS for 20 min, washed extensively with PBS and per-
meabilized in 0.1% Triton for 20 min. After washing, dishes were
blocked in a mixture of 10% FBS and 0.25% Saponin in PBS for
40 min, then probed overnight at 4 °C with rabbit anti-eIF4G and
mouse anti-I3 antibodies diluted in blocking buffer. Samples were
washed three times with PBS-0.025% Saponin then probed for
40 min with Alexaﬂuor 555-conjugated donkey anti-rabbit and Alex-
aﬂuor 488-conjugated donkey anti-mouse secondary antibodies (Mo-
lecular Probes) in blocking buffer. Samples were washed three times
PBS-0.025% Saponin, DNA was stained with Hoechst for 5 min and
washed again in PBS-0.025% Saponin, followed by washes in PBS
and water. Images were captured using a Zeiss Axioplan 2 microscope
and imaging system.
Immunoprecipitation, 7-Methyl GTP chromatography and ssDNA binding
assay
Anti-eIF4G and anti-PABP immunoprecipitation from metabolical-
ly labeled cell extracts was performed as described previously (Walsh
and Mohr, 2006). Brieﬂy, after labeling, soluble cell extracts were pre-
pared in NP-40 lysis buffer (NLB) and centrifuged at 13,000 rpm for
10 min at 4 °C. Extracts were treated with a cocktail of nucleases
(RNAse A, RNase T1 and Micrococcal Nuclease) then precleared and
immunoprecipitated as described (Walsh and Mohr, 2006). For 7-
Methyl GTP chromatography, 107 cells were washed in PBS then
lysed in 600 μl NLB, treated with RNAse A and precleared with 80 μl
packed-bed volume (pbv) BSA-blocked sepharose 4B for 1 h. Input
samples were taken from precleared extracts and the remaining sam-
ple was incubated with 50 μl pbv BSA-blocked 7-Methyl GTP-
Sepharose (Amersham) for 1 h then washed in NLB and boiled in
Laemmli buffer. For ssDNA-binding assays, 3×107 cells were
washed in PBS then lysed in NLB and centrifuged at 13,000 rpm for
10 min at 4 °C. Extracts were treated with RNAse A for 20 min at
room temperature then treated with RNAse Inhibitor (Sigma-
Aldrich) to stop the RNAse reaction prior to the addition of ssDNA.
Extracts were precleared for 1 h with anti-biotin antibody conjugated
sepharose 4B (Sigma Aldrich). Precleared extracts were then pro-
grammed with 7.5 μg phosphothioate-stabilized 5′-biotin conjugated
ssDNA (sequence: ataattaataacaccatagaccaccgcccgaaggg) and 20 μl
p.b.v. anti-biotin antibody-conjugated sepharose 4B for 2 h at 4 °C.
Resin was recovered and washed extensively in NLB before boiling
in Laemmli buffer.
Antibodies and chemicals
Anti-eIF4G antiserum was a kind gift of Ian Mohr, NYU Langone
School of Medicine, New York, USA. Anti-PABP antiserum was a
kind gift of Simon Morley, University of Sussex, UK. Rabbit anti-I3 an-
tiserum was a kind gift of Jacomine Krijnse-Locker, EMBL Heidelburg,
Germany. Mouse monoclonal anti-I3 was a kind gift of David Evans
and Nicole Favis, University of Alberta, Canada. Anti-eIF4E antibody
was from BD Transduction Laboratories. Anti-4E-BP1 and antibodies
against the phosphorylated and total forms of Akt were obtained
from Cell Signaling Technology. Anti-Vaccinia Virus antibody was
from Virostat. Anti-FLAG and anti-histidine antibodies together with
PAA were from Sigma-Aldrich.
Silver staining and mass spectrometry analysis
After resolution of samples by SDS-PAGE, gels were sequentially
soaked for 10 min in 50% Methanol, 5% Methanol, 30 μM DTT, 0.1%
21I. Zaborowska et al. / Virology 425 (2012) 11–22(w/v) AgNO3, then visualized with 3% (w/v) Na2CO3. Bands were ex-
cised from silver stained gels and destained using a 1:1 mixture of
30 mM potassium ferricyanide/100 mM sodium thiosulfate solution.
In-gel digestion using sequence grade trypsin (Promega) at a concen-
tration of 12.5 ng/μl trypsin in 10 mM ammonium bicarbonate con-
taining 10% (vol/vol) acetonitrile was carried out overnight at 37 °C.
Tryptic peptides generated were extracted and analyzed by LC-MS/
MS using an LTQ ion trap mass spectrometer (Thermo Fisher Scientif-
ic). The data generated was searched using BioWorks 3.3.1 (Thermo
Fisher Scientiﬁc) against a subset of human and viral proteins from
the SwissProt database.
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